Pimobendan

Pimobendan is a medication used to treat congestive heart failure in dogs. It is a type of medication known as a “positive inotropic agent”, meaning it works by increasing the strength of the heart muscle’s contractions. It is often prescribed when other treatments such as diet and lifestyle changes have failed to produce the desired effect. Pimobendan can help improve the quality of life of dogs with heart failure and increase their longevity. Common side effects include vomiting, diarrhea, and fatigue.

Pimobendan is a medication specifically used in veterinary medicine to treat congestive heart failure (CHF) in dogs. Here's a breakdown of what Pimobendan is and how it helps canine hearts:

Type of drug: Pimobendan is classified as a positive inotropic and vasodilator.

How it works: Pimobendan works in two ways to improve heart function in dogs with CHF:

  • Positive inotropic effect: It strengthens the heart muscle's contractions, allowing it to pump blood more efficiently.
  • Vasodilator effect: It relaxes blood vessels, particularly those in the lungs and throughout the body. This helps to reduce blood pressure and makes it easier for the heart to pump blood.

What it's used for: Pimobendan is primarily used for dogs diagnosed with CHF, usually caused by:

  • Dilated cardiomyopathy: A weakening and enlargement of the heart muscle.
  • Valvular insufficiency: Leaky heart valves that prevent blood from flowing efficiently.

Benefits: Studies have shown that Pimobendan can improve:

  • Exercise tolerance and stamina in dogs with CHF.
  • Quality of life for dogs with CHF.
  • Survival rates for dogs with CHF, particularly those with mitral valve disease.

Important considerations:

  • Pimobendan is typically given orally twice a day.
  • It is often used in combination with other medications for CHF, like diuretics.
  • Pimobendan is not without potential side effects, such as diarrhea, vomiting, and lethargy. Regular veterinary monitoring is crucial.
  • Pimobendan is not approved for use in cats or other animals.
Anatomical Therapeutic Chemical Classification
QC - Cardiovascular system
QC01 Cardiac therapy
QC01C - Cardiac stimulants excluding cardiac glycosides
QC01CE Phosphodiesterase inhibitors
Anatomical Therapeutic Chemical Classification
QC - Cardiovascular system
QC09 Agents acting on the renin–angiotensin system
QC09B - ACE inhibitors, combinations
QC09BX ACE inhibitors, other combinations
External Links